Lipids and Lipid Compositions for the Delivery of Active Agents
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 61/774,759, filed Mar 8, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,124,065 | Lipids and Lipid Compositions for the Delivery of Active Agents In force · High confidence UsedRemaining | Novartis AG | In force | High confidence | ||
| US 10,792,361 | Lipids and Lipid Compositions for the Delivery of Active Agents In force · High confidence | Novartis AG | In force | High confidence | ||
| US 9,504,747 | Lipids and Lipid Compositions for the Delivery of Active Agents In force · High confidence | Novartis AG | In force | High confidence | ||
| US 10,729,775 | Lipids and Lipid Compositions for the Delivery of Active Agents In force · Medium confidence | Novartis AG | In force | Medium confidence | ||
| US 10,227,588 | 3'END CAPS FOR RNAi AGENTS FOR USE IN RNA INTERFERENCE In force · High confidence | Novartis AG | In force | High confidence | ||
| US 10,519,446 | Organic Compounds to Treat Hepatitis B Virus In force · High confidence | Novartis AG | In force | High confidence | ||
| US 11,008,570 | 3'END CAPS FOR RNAi AGENTS FOR USE IN RNA INTERFERENCE In force · High confidence | Novartis AG | In force | High confidence | ||
| US 9,988,627 | Novel Formats for Organic Compounds for Use in RNA Interference In force · High confidence | Novartis AG | In force | High confidence | ||
| US 10,059,655 | Lipids and Lipid Compositions for the Delivery of Active Agents In force · High confidence | Novartis AG | In force | High confidence | ||
| US 10,906,867 | Lipids and Lipid Compositions for the Delivery of Active Agents In force · High confidence | Novartis AG | In force | High confidence | ||
| 7 more records in this group · Pro | ||||||
10 of 17 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 17.
16 of these are in force and held by Novartis AG.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.